Drugs / DS-5573a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02192567 | Sep 2014 → Jan 2017 | cancer | Daiichi Sankyo | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DS-5573a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02192567 ↗ |
| Route | Intravenous | “starting intravenous (IV) dose of 0.1 mg/kg” NCT02192567 ↗ |